GH Research (GHRS) News Today $9.09 +0.12 (+1.34%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period GH Research: Promising Developments and Financial Stability Justify Buy RatingNovember 16 at 7:09 AM | markets.businessinsider.comGH Research’s Promising Clinical Progress and Financial Strength Reaffirm Buy Rating with $39 Price TargetNovember 16 at 7:09 AM | markets.businessinsider.comGH Research (NASDAQ:GHRS) Stock Price Up 0.1% - Time to Buy?GH Research (NASDAQ:GHRS) Trading 0.1% Higher - Should You Buy?November 15 at 1:37 PM | marketbeat.comGH Research (NASDAQ:GHRS) Shares Up 0.2% - Here's What HappenedGH Research (NASDAQ:GHRS) Trading 0.2% Higher - Here's WhyNovember 14 at 3:15 PM | marketbeat.comGH Research PLC: GH Research Reports Third Quarter 2024 Financial Results and Provides Business UpdatesNovember 14 at 12:03 PM | finanznachrichten.deGH Research Reports Third Quarter 2024 Financial Results and Provides Business UpdatesNovember 14 at 7:00 AM | globenewswire.comGH Research (NASDAQ:GHRS) Stock Price Up 3.8% - Here's WhyGH Research (NASDAQ:GHRS) Stock Price Up 3.8% - Here's What HappenedNovember 13, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Stock Price Up 4.1% - Still a Buy?GH Research (NASDAQ:GHRS) Trading 4.1% Higher - What's Next?November 12, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Trading 3.1% Higher - Here's What HappenedGH Research (NASDAQ:GHRS) Stock Price Up 3.1% - Here's What HappenedNovember 11, 2024 | marketbeat.com3 Fast-Growing Stocks Analysts See Doubling in Price (GHRS)Clinical-stage biotech firms often have massive upside potential, but much of that possible success hinges on successful trials and product launches.November 11, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Trading Up 0.6% - What's Next?GH Research (NASDAQ:GHRS) Trading 0.6% Higher - Should You Buy?November 8, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Trading Down 0.9% - Should You Sell?GH Research (NASDAQ:GHRS) Shares Down 0.9% - Here's WhyNovember 7, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Trading Up 2.1% - What's Next?GH Research (NASDAQ:GHRS) Trading Up 2.1% - Here's WhyNovember 6, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Stock Price Up 0.6% - Time to Buy?GH Research (NASDAQ:GHRS) Stock Price Up 0.6% - Still a Buy?November 5, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Shares Up 0.7% - Still a Buy?GH Research (NASDAQ:GHRS) Trading Up 0.7% - What's Next?November 4, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Trading Up 2.2% - Here's What HappenedGH Research (NASDAQ:GHRS) Trading Up 2.2% - Here's What HappenedNovember 1, 2024 | marketbeat.comMorgan Stanley Reaffirms Their Buy Rating on Guardant Health (GH)November 1, 2024 | markets.businessinsider.comGH Research PLC (NASDAQ:GHRS) Sees Significant Growth in Short InterestGH Research PLC (NASDAQ:GHRS - Get Free Report) was the recipient of a significant growth in short interest during the month of October. As of October 15th, there was short interest totalling 1,780,000 shares, a growth of 11.3% from the September 30th total of 1,600,000 shares. Approximately 5.9% of the company's stock are short sold. Based on an average daily trading volume, of 44,300 shares, the short-interest ratio is currently 40.2 days.October 31, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Stock Price Down 1% - Time to Sell?GH Research (NASDAQ:GHRS) Stock Price Down 1% - Time to Sell?October 31, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Stock Price Up 2.8% - Still a Buy?GH Research (NASDAQ:GHRS) Stock Price Up 2.8% - Here's WhyOctober 30, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Shares Down 0.1% - What's Next?GH Research (NASDAQ:GHRS) Stock Price Down 0.1% - Time to Sell?October 29, 2024 | marketbeat.comHunger hormone suppressed by intense exercise, study suggestsOctober 29, 2024 | msn.comGH Research (NASDAQ:GHRS) Trading Up 3.3% - What's Next?GH Research (NASDAQ:GHRS) Stock Price Up 3.3% - Still a Buy?October 28, 2024 | marketbeat.comFDA is said to see “path forward” for ecstasy-based drugOctober 19, 2024 | msn.comGH Research (NASDAQ:GHRS) Stock Quotes, Forecast and News SummaryOctober 11, 2024 | benzinga.comGH Research PLC (NASDAQ:GHRS) Shares Bought by Lynx1 Capital Management LPLynx1 Capital Management LP grew its position in GH Research PLC (NASDAQ:GHRS - Free Report) by 19.8% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 3,966,726 shares of the company's stock after purchasing an additiSeptember 27, 2024 | marketbeat.comGH Research PLC (NASDAQ:GHRS) to Post FY2024 Earnings of ($0.75) Per Share, HC Wainwright ForecastsGH Research PLC (NASDAQ:GHRS - Free Report) - Equities researchers at HC Wainwright upped their FY2024 EPS estimates for GH Research in a report issued on Thursday, September 5th. HC Wainwright analyst P. Trucchio now anticipates that the company will post earnings per share of ($0.75) for the yeSeptember 9, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Given "Buy" Rating at HC WainwrightHC Wainwright restated a "buy" rating and issued a $40.00 price objective on shares of GH Research in a research report on Thursday.September 5, 2024 | marketbeat.comBuy Rating Affirmed on GH Research Amid Anticipated Phase 2 Advances and Strong Market PotentialSeptember 5, 2024 | markets.businessinsider.comIrish Biotech Firm GH Research Sees Cash Decline in Q2, Advances Psychedelic Drug TrialsSeptember 5, 2024 | msn.comMaintaining Buy Rating on GH Research Amidst CEO Transition and Promising GH001 TrialsSeptember 5, 2024 | markets.businessinsider.comBuy Rating Affirmed for GH Research Amid Anticipated Clinical Advances and Strong LeadershipSeptember 4, 2024 | markets.businessinsider.comJMP Securities Reaffirms Market Outperform Rating for GH Research (NASDAQ:GHRS)JMP Securities reiterated a "market outperform" rating and issued a $39.00 price target on shares of GH Research in a research note on Wednesday.September 4, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Issues Earnings Results, Beats Expectations By $0.03 EPSGH Research (NASDAQ:GHRS - Get Free Report) posted its earnings results on Tuesday. The company reported ($0.20) EPS for the quarter, beating analysts' consensus estimates of ($0.23) by $0.03.September 4, 2024 | marketbeat.comGH Research Names Velichka Villy Valcheva CEO - Quick FactsSeptember 3, 2024 | nasdaq.comGH Research (NASDAQ:GHRS) Shares Gap Down to $10.50GH Research (NASDAQ:GHRS) Shares Gap Down to $10.50September 3, 2024 | marketbeat.comGH Research Reports Second Quarter 2024 Financial Results and Provides Business UpdatesSeptember 3, 2024 | globenewswire.comGH Research Announces Appointment of Dr. Velichka “Villy” Valcheva to Chief Executive OfficerSeptember 3, 2024 | globenewswire.comGH Research (NASDAQ:GHRS) Shares Down 4% GH Research (NASDAQ:GHRS) Shares Down 4%August 26, 2024 | marketbeat.comGH Research PLC (1KA.F)August 24, 2024 | uk.finance.yahoo.comGH Research PLC (1KA.SG)August 22, 2024 | uk.finance.yahoo.comGH Research (NASDAQ:GHRS) Stock Price Up 2.6%GH Research (NASDAQ:GHRS) Stock Price Up 2.6%August 22, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Shares Gap Up to $10.57GH Research (NASDAQ:GHRS) Shares Gap Up to $10.57August 20, 2024 | marketbeat.comEquities Analysts Offer Predictions for GH Research PLC's Q1 2025 Earnings (NASDAQ:GHRS)GH Research PLC (NASDAQ:GHRS - Free Report) - Investment analysts at HC Wainwright issued their Q1 2025 EPS estimates for shares of GH Research in a research report issued to clients and investors on Wednesday, July 31st. HC Wainwright analyst P. Trucchio anticipates that the company will post eaAugust 2, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Receives "Buy" Rating from HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $40.00 price objective on shares of GH Research in a report on Wednesday.July 31, 2024 | marketbeat.comGHRS GH Research PLCJuly 19, 2024 | seekingalpha.comGH Research (NASDAQ:GHRS) Shares Gap Up to $11.37GH Research (NASDAQ:GHRS) Shares Gap Up to $11.37July 11, 2024 | marketbeat.comGH Research (NASDAQ:GHRS) Shares Up 4.7%GH Research (NASDAQ:GHRS) Trading 4.7% HigherJuly 9, 2024 | marketbeat.com3 Psychedelic Stocks to Ride to the Moon and BeyondJuly 6, 2024 | investorplace.comGH Research (NASDAQ:GHRS) Trading Down 2.6%GH Research (NASDAQ:GHRS) Stock Price Down 2.6%July 3, 2024 | marketbeat.com Get GH Research News Delivered to You Automatically Sign up to receive the latest news and ratings for GHRS and its competitors with MarketBeat's FREE daily newsletter. Email Address Urgent: This election is rigged (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soon Click here to watch it now. GHRS Media Mentions By Week GHRS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GHRS News Sentiment▼0.380.56▲Average Medical News Sentiment GHRS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GHRS Articles This Week▼121▲GHRS Articles Average Week Get GH Research News Delivered to You Automatically Sign up to receive the latest news and ratings for GHRS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Revance Therapeutics News Sangamo Therapeutics News Design Therapeutics News Atai Life Sciences News Castle Biosciences News PMV Pharmaceuticals News Centessa Pharmaceuticals News Disc Medicine News Galapagos News Recursion Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GHRS) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GH Research PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share GH Research With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
